Dark Forest Capital Management LP Sells 1,693 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Dark Forest Capital Management LP cut its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 45.5% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,024 shares of the company's stock after selling 1,693 shares during the period. Dark Forest Capital Management LP's holdings in HCA Healthcare were worth $650,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. FinTrust Capital Advisors LLC grew its position in HCA Healthcare by 26.7% during the fourth quarter. FinTrust Capital Advisors LLC now owns 166 shares of the company's stock worth $45,000 after buying an additional 35 shares in the last quarter. Lake Street Advisors Group LLC grew its position in HCA Healthcare by 1.3% during the second quarter. Lake Street Advisors Group LLC now owns 2,732 shares of the company's stock worth $878,000 after buying an additional 35 shares in the last quarter. Financial Counselors Inc. grew its position in HCA Healthcare by 1.4% during the first quarter. Financial Counselors Inc. now owns 2,642 shares of the company's stock worth $881,000 after buying an additional 36 shares in the last quarter. Premier Path Wealth Partners LLC grew its position in HCA Healthcare by 2.7% during the second quarter. Premier Path Wealth Partners LLC now owns 1,393 shares of the company's stock worth $448,000 after buying an additional 36 shares in the last quarter. Finally, Westside Investment Management Inc. grew its position in HCA Healthcare by 14.7% during the second quarter. Westside Investment Management Inc. now owns 289 shares of the company's stock worth $93,000 after buying an additional 37 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

Insider Activity

In other news, SVP Christopher F. Wyatt sold 4,000 shares of the company's stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the sale, the senior vice president now directly owns 40,449 shares of the company's stock, valued at approximately $14,569,729.80. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares of the company's stock, valued at approximately $11,438,494.76. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Christopher F. Wyatt sold 4,000 shares of the firm's stock in a transaction that occurred on Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the transaction, the senior vice president now directly owns 40,449 shares in the company, valued at $14,569,729.80. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 17,202 shares of company stock valued at $6,407,273. 1.60% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on HCA shares. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $392.00 price objective on shares of HCA Healthcare in a report on Monday, August 19th. Wells Fargo & Company boosted their target price on HCA Healthcare from $315.00 to $365.00 and gave the stock an "equal weight" rating in a report on Tuesday, July 30th. Baird R W raised HCA Healthcare to a "strong-buy" rating in a report on Thursday, May 30th. Royal Bank of Canada boosted their target price on HCA Healthcare from $378.00 to $405.00 and gave the stock an "outperform" rating in a report on Friday, August 23rd. Finally, Robert W. Baird began coverage on HCA Healthcare in a report on Thursday, May 30th. They issued an "outperform" rating and a $396.00 target price on the stock. Five investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have issued a strong buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $359.89.

HCA Healthcare Trading Down 0.1 %

Shares of HCA Healthcare stock traded down $0.51 on Friday, hitting $403.35. 823,099 shares of the company's stock traded hands, compared to its average volume of 1,137,271. The firm's 50-day moving average price is $377.28 and its two-hundred day moving average price is $342.63. The stock has a market capitalization of $105.64 billion, a PE ratio of 19.95, a price-to-earnings-growth ratio of 1.52 and a beta of 1.67. HCA Healthcare, Inc. has a one year low of $215.96 and a one year high of $409.42. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.97 by $0.53. The company had revenue of $17.49 billion during the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The firm's revenue was up 10.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $4.29 EPS. On average, research analysts expect that HCA Healthcare, Inc. will post 22.46 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be issued a $0.66 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.65%. HCA Healthcare's payout ratio is 13.16%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.